Spectral Medical Inc. Announces C$5 Million Bought Deal Convertible Note Financing
August 10, 2023 07:00 ET
|
Spectral Medical Inc.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF...
Spectral Medical Announces Tigris Clinical Trial Update
July 25, 2023 08:00 ET
|
Spectral Medical Inc.
TORONTO, July 25, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Announces the Opening of Three Additional Tigris Clinical Trial Sites
July 05, 2023 08:00 ET
|
Spectral Medical Inc.
TORONTO, July 05, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Appoints Former FDA Director, Dr. David W. Feigal, Jr., to Its Board of Directors
June 27, 2023 08:00 ET
|
Spectral Medical Inc.
TORONTO, June 27, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Provides Update on Continued Favorable Tigris Clinical Trial Enrollment
June 20, 2023 08:00 ET
|
Spectral Medical Inc.
Tigris trial enrollment at 64 patients Crude mortality results continue to exceed expectations TORONTO, June 20, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the...
Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders
June 08, 2023 16:00 ET
|
Spectral Medical Inc.
TORONTO, June 08, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Provides Update on Favorable Tigris Clinical Trial Enrollment
May 30, 2023 08:00 ET
|
Spectral Medical Inc.
Reports significant uptick in enrollment activities Tigris trial enrollment at 61 patients TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT),...
Spectral Medical Hosts Successful Investigator Meeting; Expected to Help Bolster Enrollment Activities
May 24, 2023 08:00 ET
|
Spectral Medical Inc.
TORONTO, May 24, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Announces First Quarter Results and Provides Corporate Update
May 12, 2023 08:00 ET
|
Spectral Medical Inc.
New Trial Sites Enroll 60% of New Patient Enrollments Since the Beginning of April Tigris Patient Enrollment at 58 Patients TORONTO, May 12, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc....
Spectral Medical Inc. Announces Director Resignation
May 04, 2023 16:00 ET
|
Spectral Medical Inc.
TORONTO, May 04, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...